Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Sarcoma 54Lymphoma 40Lymphoma, Large B-Cell, Diffuse 28Lymphoma, Non-Hodgkin 21Hodgkin Disease 18Precursor Cell Lymphoblastic Leukemia-Lymphoma 17Osteosarcoma 17Testicular Neoplasms 15Burkitt Lymphoma 15Leukemia 14Lymphoma, Large-Cell, Immunoblastic 13Lymphoma, Follicular 13Ovarian Neoplasms 12Lymphoma, Mantle-Cell 12Neuroectodermal Tumors, Primitive, Peripheral 11Testicular Germ Cell Tumor 10Liposarcoma 10Histiocytoma, Malignant Fibrous 10Hemangiosarcoma 10Fibrosarcoma 10Sarcoma, Synovial 9Rhabdomyosarcoma 9Neurofibrosarcoma 9Lymphoma, Large-Cell, Anaplastic 9Leiomyosarcoma 9Teratoma 8Recurrence 8Neuroblastoma 8Lymphoma, B-Cell, Marginal Zone 8Leukemia, Lymphocytic, Chronic, B-Cell 8

Interventions

Vincristine 1Topotecan 1Razoxane 1Ifosfamide 1Etoposide 1Doxorubicin 1Dexrazoxane 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Localized Extraskeletal Ewing Sarcoma × Ifosfamide × Clear all
NCT01231906 2026-01-23

Combination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing Sarcoma

Children's Oncology Group

Phase 3 Completed
642 enrolled 11 charts
Sarcoma

Localized Extraskeletal Ewing Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡